Global

Aug 06, 2018
Pharmaceutical Executive
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Aug 01, 2018
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.
Jul 31, 2018
By Pharmaceutical Executive Editors
Jul 31, 2018
By Pharmaceutical Executive Editors
Jul 19, 2018
With China predicted to account for 48% of the global diabetes population by 2045, Jin Zhang looks at how the country's domestic pharma companies are faring in this treatment area.
Jul 09, 2018
Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Jul 07, 2018
Pharmaceutical Executive
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 21, 2018
China's nurse educator program aims to improve quality of care and make life simpler for physicians handling high patient load. Sebastian Bather reports.
native1_300x100
lorem ipsum